This article was originally published on ETFTrends.com.
Healthcare stocks and healthcare ETFs were among the worst performing areas of the S&P 500 Monday as Celgene (NasdaqGS: CELG) shares plunged in response to Morgan Stanley’s projecting that a key experimental drug could be delayed. The Health Care Select Sector SPDR (NYSEArca: XLV), the largest healthcare exchange traded fund, fell 0.7% Monday and was […]
Continue Reading Below
